Form 4 for TDOC Teladoc Health, Inc.
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-17 · accession 0001415889-22-005230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-18 | 2022-05-17 | TDOC | Daniel Karen L | Dir | M - OptEx | — | +1,638 | 43.9K | +4% | — |
| D | 2022-05-18 | 2022-05-17 | TDOC | Daniel Karen L | Dir | M - OptEx | $0.00 | -1,638 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | M | A | 1,638 | — | 43,880 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-05-17 | M | D | 1,638 | $0.00 | 0 | D | — · — to — | 1,638 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. |